HTG MOLECULAR DIAGNOSTICS IN
Q3 2021 13F Holders
CUSIP
40434H203
Type
Equity
Class
COM NEW
Num filings
24
Total reported value, excl. options
$16.4 M
Compare 2021 Q3 to
2022 Q3
2022 Q2
2022 Q1
2021 Q4
2021 Q2
2021 Q1
2020 Q4
Manager
Report Date
Value ($000)
Shares
Option Type